{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:54:52Z","timestamp":1777463692114,"version":"3.51.4"},"reference-count":32,"publisher":"Impact Journals, LLC","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,4,20]]},"DOI":"10.18632\/oncotarget.25095","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T20:09:50Z","timestamp":1524254990000},"page":"21337-21347","source":"Crossref","is-referenced-by-count":28,"title":["IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy"],"prefix":"10.18632","volume":"9","author":[{"given":"Giacomo","family":"Quattrocchio","sequence":"first","affiliation":[{"name":"Nephrology and Dialysis Unit, San Giovanni Bosco Hospital, and University of Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Barreca","sequence":"additional","affiliation":[{"name":"Division of Pathology, Department of Medical Sciences, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Demarchi","sequence":"additional","affiliation":[{"name":"Surgical Pathology Unit, San Giovanni Bosco Hospital, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Solfietti","sequence":"additional","affiliation":[{"name":"Center of Research of Immunopathology and Rare Diseases (CMID), San Giovanni Bosco Hospital, and University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulietta","family":"Beltrame","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, San Giovanni Bosco Hospital, and University of Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Fenoglio","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, San Giovanni Bosco Hospital, and University of Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Ferro","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, San Giovanni Bosco Hospital, and University of Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Mesiano","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, San Giovanni Bosco Hospital, and University of Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Murgia","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, San Giovanni Bosco Hospital, and University of Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Del Vecchio","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, San Giovanni Bosco Hospital, and University of Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Massara","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, San Giovanni Bosco Hospital, and University of Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Rollino","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, San Giovanni Bosco Hospital, and University of Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Roccatello","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, San Giovanni Bosco Hospital, and University of Turin, Italy"},{"name":"Center of Research of Immunopathology and Rare Diseases (CMID), San Giovanni Bosco Hospital, and University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2018,4,20]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Deshpande","year":"2012","journal-title":"N Engl J Med"},{"key":"2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1146\/annurev-pathol-012513-104708","article-title":"IgG4-related disease","volume":"9","author":"Stone","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"3","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"385","author":"Stone","year":"2015","journal-title":"Lancet"},{"key":"4","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.autrev.2014.08.013","article-title":"The clinical spectrum of IgG4-related disease","volume":"13","author":"Stone","year":"2014","journal-title":"Autoimmun Rev"},{"key":"5","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.mayocp.2015.03.020","article-title":"Diagnostic Approach to the Complexity of IgG4-Related Disease","volume":"90","author":"Ramos-Casals","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"6","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/art.39205","article-title":"IgG4-related disease: Clinical and laboratory features in 125 patients","volume":"67","author":"Stone","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"7","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/modpathol.2013.236","article-title":"T helper 2 and regulatory T-cell cytokine production by mast cells: a key factor in the pathogenesis of IgG4-related disease","volume":"27","author":"Yoshino","year":"2014","journal-title":"Mod Pathol"},{"key":"8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrneph.2015.95","article-title":"IgG4-related disease and the kidney","volume":"11","author":"Stone","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nrrheum.2013.183","article-title":"Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist","volume":"10","author":"Shinomura","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3109\/14397595.2014.1001474","article-title":"Immunohistological analysis for immunological response and mechanism of interstitial fibrosis in IgG4-related kidney disease","volume":"25","author":"Saito","year":"2015","journal-title":"Mod Rheumatol"},{"key":"11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MNH.0000000000000102","article-title":"IgG4-related kidney disease - an update","volume":"24","author":"Saeki","year":"2015","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s40620-016-0279-4","article-title":"IgG4-related nephropathy","volume":"29","author":"Roccatello","year":"2016","journal-title":"J Nephrol"},{"key":"13","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1681\/ASN.2011010062","article-title":"Diagnosis of IgG4-Related Tubulointerstitial Nephritis","volume":"22","author":"Cornell","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10157-011-0521-2","article-title":"Proposal for diagnostic criteria for IgG4-related kidney disease","volume":"15","author":"Umehara","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.prp.2015.03.004","article-title":"IgG4-related kidney disease - A review","volume":"211","author":"Mohanty","year":"2015","journal-title":"Pathol Res Pract"},{"key":"16","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ki.2010.271","article-title":"Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis","volume":"78","author":"Homma","year":"2010","journal-title":"Kidney Int"},{"key":"17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ki.2013.393","article-title":"IgG4-related kidney disease","volume":"85","author":"Kawano","year":"2014","journal-title":"Kidney Int"},{"key":"18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/MD.0b013e318289610f","article-title":"Rethinking Ormond\u2019s disease: \u201cidiopathic\u201d retroperitoneal fibrosis in the era of IgG4-related disease","volume":"92","author":"Deshpande","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"19","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1007\/s00259-014-2729-3","article-title":"Characterizing IgG4-related disease with \u00b98F-FDG PET\/CT: a prospective cohort study","volume":"41","author":"Zhu","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/BOR.0b013e328341a240","article-title":"Treatment approaches to IgG4-related systemic disease","volume":"23","author":"Stone","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10157-015-1140-0","article-title":"Recovery of renal function after glucocorticoid therapy for IgG4-related kidney disease with renal dysfunction","volume":"20","author":"Saito","year":"2016","journal-title":"Clin Exp Nephrol"},{"key":"22","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/art.27435","article-title":"Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease","volume":"62","author":"Stone","year":"2010","journal-title":"Arthritis Rheum"},{"key":"23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MD.0b013e3182431ef6","article-title":"Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients","volume":"91","author":"Stone","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"24","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Stone","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.berh.2016.07.003","article-title":"IgG4-related disease: Advances in the diagnosis and treatment","volume":"30","author":"Stone","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"26","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1093\/ndt\/gfr109","article-title":"Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy","volume":"26","author":"Modena","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/nrrheum.2011.56","article-title":"Therapy. Rituximab for refractory SLE-patients reach lasting remission with short-term regimen","volume":"7","author":"Leah","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"28","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.autrev.2015.07.017","article-title":"A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment","volume":"14","author":"Menegatti","year":"2015","journal-title":"Autoimmun Rev"},{"key":"29","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Brugge","year":"2012","journal-title":"Mod Pathol"},{"key":"30","doi-asserted-by":"publisher","first-page":"e1366","DOI":"10.1097\/MD.0000000000001366","article-title":"Rituximab for the treatment of IgG4-related tubulointerstitial nephritis: case report and review of the literature","volume":"94","author":"Atta","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"31","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39132","article-title":"International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease","volume":"67","author":"Kawa","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"32","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3109\/14397595.2014.931908","article-title":"Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis","volume":"25","author":"Yoo","year":"2015","journal-title":"Mod Rheumatol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:40:20Z","timestamp":1589042420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,20]]},"references-count":32,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2018,4,20]]}},"alternative-id":["25095","29765543"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.25095","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,20]]}}}